Siemens Healthineers raises $5.2B with IPO

Michael Walter | | Radiology Business | Economics

Siemens’ healthcare division, Siemens Healthineers, began trading on Germany’s stock exchange Friday, raising $5.2 billion (4.2 billion euros) by selling 15 percent of the company. Shares were issued at 28 euros each but opened at 29.10 euros each.

The initial public offering (IPO) has been in the works for months, with numerous reports indicating it could occur by the end of March. This is widely viewed as one of the biggest public equity offerings in the history of Germany’s stock market.

Technical difficulties with Deutsche Boerse’s trading platform delayed the launch by more than an hour. Bernd Montag, Siemens Healthineers CEO, said in an interview with CNBC that it ultimately “didn’t make a big difference and we are happy that we made it anyway.”

The IPO is designed to help Siemens Healthineers fund future acquisitions and investments. There are also financial benefits to having stock to offer in future business dealings as opposed to cash.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Congress ditches doc fix in stopgap end-of-year funding bill
Teleradiology provider inks post-acute care deal worth $1.5M annually
US Radiology Specialists affiliate expands into new market
Radiologist rails against insurer’s refusal to cover key interventional service
Blue Cross Blue Shield affiliate rejects MRI contrast coverage, labeling it ‘investigational’

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.